Nalbuphine: Clinical Trials

100 trials of Nalbuphine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

51 completed, 21 unknown, 14 recruiting, 9 not yet recruiting. 35 Not applicable, 25 Phase 4, 18 Phase 2, 13 Phase 3, 12 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable35Completed 19, Unknown 6, Not yet recruiting 4, Recruiting 3, Terminated 3
Phase 425Completed 8, Unknown 8, Not yet recruiting 4, Recruiting 4, Active not recruiting 1
Phase 218Completed 12, Recruiting 3, Unknown 3
Phase 313Completed 9, Recruiting 4
Phase 112Completed 6, Unknown 3, Not yet recruiting 1, Recruiting 1, Terminated 1
Early Phase 12Unknown 2

Follow Nalbuphine: new trials by email Literature Review of Nalbuphine trials Research Report on Nalbuphine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
NAL ER, Quinidine Sulfate - Healthy Participants
Phase 1RecruitingTrevi Therapeutics302026-11-032026-11-18
Ultrasound-Guided Ilioinguinal-Iliohypogastric Nerve Block Following Spinal Anesthesia Comparing Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Unilateral Inguinal Hernia Repair
Bupivacaine, Nalbuphine, Dexmedetomidine - Inguinal Hernia, Postoperative Pain
Phase 4Not yet recruitingAssiut University1022026-10-012026-09-23
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine (NAL) Extended-Release (ER) Tablets
NAL ER, Placebo - Idiopathic Pulmonary Fibrosis
Phase 3RecruitingTrevi Therapeutics2012026-09-302026-11-13
Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
NAL ER, Placebo - Idiopathic Pulmonary Fibrosis
Phase 3RecruitingTrevi Therapeutics3062026-06-292026-11-13
The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)
NAL ER, Placebo - Refractory Chronic Cough
Phase 2RecruitingTrevi Therapeutics1002026-06-222026-11-05
FASCIA ILIACA BLOCK VERSUS INTRAVENOUS NALBUPHINE AS ANALGESIC METHOD BEFORE POSITIONING FOR SPINAL ANESTHESIA IN PATIENTS UNDERGOING SURGERY FOR HIP FRACTURES
Bupivacain, Nalbuphine - Hip Fracture Surgeries
Phase 4Active not recruitingLiaquat National Hospital & Medical College302026-05-122026-05-29
Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery
Ketamine, Pecs block, Nalbuphine - Breast Cancer, Pain, Chronic
Not applicableNot yet recruitingAga Khan University1202026-03-162026-02-19
Intravenous Nalbuphine Versus Lidocaine for Prevention of Propofol Injection Pain
Nalbuphine, Lidocaine - Procedural Pain
Not applicableNot yet recruitingHayatabad Medical Complex922026-03-012026-02-20
A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
NAL ER - Healthy Participants
Phase 1CompletedTrevi Therapeutics602026-02-272026-08-21
Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy
Nalbuphine, Fentanyl - Laryngoscopy, Hemodynamic Changes
Phase 4RecruitingRawalpindi Institute of Cardiology982026-02-212026-02-27
Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
Anrikefon, Nalbuphine - Ophthalmic Surgery, Postoperative Pain Management
Phase 4RecruitingZhongshan Ophthalmic Center, Sun Yat-sen University2042026-01-222026-04-01
Comparison Between External Oblique Intercostal Plane Block and Rectus Sheath Block Combined With Transversus Abdominis Plane Block
External intercostal plane puncture, control group (nalbuphine), the single-puncture technique of (rectus sheath block) combined with (Transversus abdominis plane block) - Pain Management, Anesthesia , Analgesia
Not applicableNot yet recruitingMinia University602026-01-202026-02-03
Ultrasound-Guided Infraclvicular Block Using Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Upper Limb Orthopedic Surgery
Nalbuphine, Dexmedetomidine - Regional Anaesthesia
Phase 1Not yet recruitingAssiut University662026-01-012025-12-12
Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients
Nalbuphine Hydrochloride injection was administered during anesthesia induction., Nalbuphine Hydrochloride injection was administered after cement implantation., Standard general anesthesia regimen ( nalbuphine was not administered throughout the entire anesthesia process.) - Postoperative Pain, Acute, Hemodynamics
Phase 4RecruitingQianfoshan Hospital1622025-10-282025-12-09
Analgosedation With Ketamine, Nalbuphine, or Dexmedetomidine for Suture Removal in Children After Cleft Surgery
ketamine, Nalbuphine, Dexmedetomidine - Orofacial Clefts, Cleft Lip and Palate
Not applicableRecruitingUniversity Medical Centre Ljubljana602025-09-012026-01-14
Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management
Nalbuphine Injection, Next Generation Sequencing, whole exome sequencing - Cholecystectomy, Hernia, Abdominal
Phase 2 / Phase 3RecruitingDr. Asma Abdus Salam2632025-09-012026-04-15
NAL ER IPF Respiratory Function and Safety Study
NAL ER, Placebo - Idiopathic Pulmonary Fibrosis
Phase 1CompletedTrevi Therapeutics92025-08-212026-08-03
Nalbuphine Dosing and Its Impact on Anxiety and Depression in Ectopic Pregnancy Surgery
Nalbuphine 0.20mg/ml(total 30 mg), Nalbuphine 0.27mg/ml(total 40 mg), Nalbuphine 0.33mg/ml(total 50 mg) - Ectopic Pregnancy, Anxiety
Not applicableNot yet recruitingChengdu Jinjiang Maternity and Child Health Hospital1652025-06-202025-06-08
Erector Spinae Plane Block for Analgesia During ESWL
erector spinae plane block, Nalbuphine - Renal Stone
Not applicableCompletedSohag University602025-06-132026-07-28
Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.
Dezocine and Sufentanil combination, Nalbuphine and Sufentanil combination - Oral Cancer, Postoperative Pain Management
Not applicableRecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University602025-06-012026-02-10

Showing 20 of 100. Sign in to see all of them.

Conditions studied

Pain, Postoperative (18)  ·  Pain (8)  ·  Agnosia (7)  ·  Idiopathic Pulmonary Fibrosis (5)  ·  Pruritus (5)  ·  Emergence Delirium (4)  ·  Cough (3)  ·  Postoperative Nausea and Vomiting (3)  ·  Acute Pain (2)  ·  Chronic Cough (2)  ·  Hernia, Inguinal (2)  ·  Labor Pain (2)  ·  Respiratory Insufficiency (2)  ·  Adrenal Insufficiency (1)  ·  Anemia, Sickle Cell (1)

Sponsors

Assiut University (16)  ·  Trevi Therapeutics (12)  ·  Ain Shams University (5)  ·  Cairo University (3)  ·  Lumosa Therapeutics Co., Ltd. (2)  ·  Minia University (2)  ·  Sun Yat-sen University (2)  ·  Tri-Service General Hospital (TSGH) (2)  ·  University of California, San Francisco (2)  ·  Zagazig University (2)  ·  Abdelrady S Ibrahim, MD (1)  ·  Aga Khan University (1)  ·  Aga Khan University Hospital, Pakistan (1)  ·  Alexandria University (1)  ·  Alzahraa Ahmed Abbas (1)

Countries

Egypt (29)  ·  China (15)  ·  United States (11)  ·  Pakistan (8)  ·  Canada (5)  ·  Taiwan (5)  ·  United Kingdom (5)  ·  Thailand (3)  ·  Germany (2)  ·  Switzerland (2)  ·  Australia (1)  ·  Chile (1)  ·  France (1)  ·  Greece (1)  ·  Hungary (1)

Top investigators

Huijing Ye (2)  ·  Jon D Levine, MD, PhD (2)  ·  Khaled Tolba Younes, Lecturer (2)  ·  A M Elhalwagy, MD (1)  ·  Abd-Elazeem A Elbakry, MD (1)  ·  Abdelrady S Ibrahim, MD (1)  ·  Ayman A Mamdouh, Ass Prof (1)  ·  Bahaa M Refaie, MD (1)  ·  Carolyne Montgomery, MD (1)  ·  Chi Hornik (1)  ·  David Nguyen, MD (1)  ·  Doaa F El Hamalawy, Lecturer (1)

Results publications

PMID 10960384, PMID 11727145, PMID 12847519, PMID 1326621, PMID 14977340, PMID 15064262, PMID 15094977, PMID 16900566, PMID 17959952, PMID 20199610, PMID 20693876, PMID 22546966, PMID 22678319, PMID 23268518, PMID 24237004, PMID 24666698, PMID 26313057, PMID 26827847, PMID 27199310, PMID 27518488, PMID 28403427, PMID 28409480, PMID 28410767, PMID 28639583, PMID 29503577, PMID 29623143, PMID 29856176, PMID 29978298, PMID 30418234, PMID 30439721, PMID 30863138, PMID 31561647, PMID 31888322, PMID 32030700, PMID 32282646, PMID 32606903, PMID 32724245, PMID 32991672, PMID 33027075, PMID 34867403, PMID 35645576, PMID 36100355, PMID 36194149, PMID 36273202, PMID 36385903, PMID 36680419, PMID 36727809, PMID 37084807, PMID 38057695, PMID 38320144

NIH funding

R01DE018526 (2), 2018 (1), 2025 (1)